218 related articles for article (PubMed ID: 17936910)
1. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kanazawa H; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Nagai T; Horii S; Hirotsu N; Kashiwagi S
J Infect; 2008 Jan; 56(1):51-7. PubMed ID: 17936910
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
[No Abstract] [Full Text] [Related]
7. The course of fever following influenza virus infection in children treated with oseltamivir.
Suzuki E; Ichihara K
J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
[TBL] [Abstract][Full Text] [Related]
8. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
[TBL] [Abstract][Full Text] [Related]
9. Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.
Toriumi Y; Kamei T; Murata K; Takahashi I; Suzuki N; Mazda O
Forsch Komplementmed; 2012; 19(4):179-86. PubMed ID: 22964983
[TBL] [Abstract][Full Text] [Related]
10. Zanamivir treatment is equally effective for both influenza A and influenza B.
Kawai N; Ikematsu H; Iwaki N; Tanaka O; Yamanishi Y; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2007 Jun; 44(12):1666. PubMed ID: 17516418
[No Abstract] [Full Text] [Related]
11. Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
Kubo T; Nishimura H
Phytomedicine; 2007 Feb; 14(2-3):96-101. PubMed ID: 17141491
[TBL] [Abstract][Full Text] [Related]
12. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
Watanabe A; Chang SC; Kim MJ; Chu DW; Ohashi Y;
Clin Infect Dis; 2010 Nov; 51(10):1167-75. PubMed ID: 20936975
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
[TBL] [Abstract][Full Text] [Related]
14. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
15. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
[TBL] [Abstract][Full Text] [Related]
16. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Carrat F; Duval X; Tubach F; Mosnier A; Van der Werf S; Tibi A; Blanchon T; Leport C; Flahault A; Mentré F;
Antivir Ther; 2012; 17(6):1085-90. PubMed ID: 22910171
[TBL] [Abstract][Full Text] [Related]
17. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
[No Abstract] [Full Text] [Related]
18. Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection.
Shinjoh M; Takano Y; Takahashi T; Hasegawa N; Iwata S; Sugaya N
Pediatr Infect Dis J; 2012 Nov; 31(11):1119-23. PubMed ID: 22634596
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic predictors of influenza virus positivity in children during the influenza season.
Ohmit SE; Monto AS
Clin Infect Dis; 2006 Sep; 43(5):564-8. PubMed ID: 16886147
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]